Q2 Earnings Forecast for Climb Bio Issued By Leerink Partnrs
Climb Bio, Inc. (NASDAQ:CLYM – Free Report) – Equities researchers at Leerink Partnrs lifted their Q2 2025 earnings estimates for Climb Bio in a research note issued to investors on Tuesday, March 25th. Leerink Partnrs analyst T. Smith now expects that the company will post earnings of ($0.15) per share for the quarter, up from […]
Climb Bio, Inc. (NASDAQ:CLYM – Free Report) – Equities researchers at Leerink Partnrs lifted their Q2 2025 earnings estimates for Climb Bio in a research note issued to investors on Tuesday, March 25th. Leerink Partnrs analyst T. Smith now expects that the company will post earnings of ($0.15) per share for the quarter, up from […]
